pet

  1. Nightsong

    Glial activation among individuals with Neurological [PASC]: A Brain Fog Positron Emission Tomography Study of [18F]-FEPPA, 2025, Clouston+

    Abstract Background: This study examined the regional distribution of glial activation in essential workers with neurological post-acute sequelae of coronavirus disease 2019 (COVID-19) infections (N-PASC). Methods: We injected ≤185 MBq of [18F]-FEPPA as an intravenous bolus and...
  2. SNT Gatchaman

    Persistent dysfunctions of brain metabolic connectivity in long-covid with cognitive symptoms, 2024, Martini et al.

    Persistent dysfunctions of brain metabolic connectivity in long-covid with cognitive symptoms Martini, Anna Lisa; Carli, Giulia; Caminiti, Silvia Paola; Kiferle, Lorenzo; Leo, Andrea; Perani, Daniela; Sestini, Stelvio PURPOSE Our study examines brain metabolic connectivity in SARS-CoV-2...
  3. SNT Gatchaman

    Frontal-striatal glucose metabolism and fatigue in patients with multiple sclerosis, long COVID, and COVID-19 recovered controls, 2024, Rudroff+

    Frontal-striatal glucose metabolism and fatigue in patients with multiple sclerosis, long COVID, and COVID-19 recovered controls Rudroff, Thorsten This study compared brain glucose metabolism using FDG-PET in the caudate nucleus, putamen, globus pallidus, thalamus, and dorsolateral prefrontal...
  4. SNT Gatchaman

    Persistent brain metabolic impairment in long COVID patients with persistent clinical symptoms: a nine-month follow-up FDG-PET study, 2024, Horowitz+

    Persistent brain metabolic impairment in long COVID patients with persistent clinical symptoms: a nine-month follow-up 18FFDG-PET study Horowitz, Tatiana; Dudouet, Pierre; Campion, Jacques-Yves; Kaphan, Elsa; Radulesco, Thomas; Gonzalez, Sandra; Cammilleri, Serge; Ménard, Amélie; Guedj, Eric...
  5. D

    Placebo and Nocebo Effects Are Defined by Opposite Opioid and Dopaminergic Responses 2008 (Claims Objective Proof of Placebo)

    Full article available: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/482600
  6. Cheshire

    Brain 18F-FDG PET imaging in outpatients with post-COV-19 conditions: findings and associations with clinical characteristics, 2022, Goehringer et al

    Abstract Background Brain 18F-FDG PET imaging has the potential to provide an objective assessment of brain involvement in post-COVID-19 conditions but previous studies of heterogeneous patient series yield inconsistent results. The current study aimed to investigate brain 18F-FDG PET findings...
Back
Top Bottom